Bosh sahifa068270 ā¢ KRX
add
Celltrion Inc
Yopilish kursi
196Ā 700,00Ā ā©
Kunlik diapazon
195Ā 300,00Ā ā© - 200Ā 500,00Ā ā©
Yillik diapazon
144Ā 615,31Ā ā© - 251Ā 000,00Ā ā©
Bozor kapitalizatsiyasi
45,12Ā trln KRW
OŹ»rtacha hajm
576,55Ā ming
Narx/foyda
41,91
Dividend daromadliligi
0,38%
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,33Ā trln | 25,06% |
Joriy xarajat | 383,06Ā mlrd | 10,26% |
Sof foyda | 528,43Ā mlrd | 123,30% |
Sof foyda marjasi | 39,73 | 78,56% |
Har bir ulushga tushum | 2,40Ā ming | 117,62% |
EBITDA | 537,36Ā mlrd | 95,28% |
Amaldagi soliq stavkasi | -0,01% | ā |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,24Ā trln | 8,40% |
Jami aktivlari | 22,33Ā trln | 6,08% |
Jami passivlari | 4,98Ā trln | 43,37% |
Umumiy kapital | 17,35Ā trln | ā |
Tarqatilgan aksiyalar | 218,61Ā mln | ā |
Narxi/balansdagi bahosi | 2,50 | ā |
Aktivlardan daromad | 5,42% | ā |
Kapitaldan daromad | 5,77% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
| (KRW) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 528,43Ā mlrd | 123,30% |
Operatsiyalardan naqd pul | 139,88Ā mlrd | -54,28% |
Sarmoyadan naqd pul | -629,48Ā mlrd | -520,17% |
Moliyadan naqd pul | 754,75Ā mlrd | 429,67% |
Naqd pulning sof oŹ»zgarishi | 309,21Ā mlrd | 1Ā 200,88% |
BoŹ»sh pul | -160,53Ā mlrd | -362,61% |
Haqida
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Tashkil etilgan
2002
Sayt
Xodimlar soni
1Ā 074
